"Southern Regional Medical Center, a member of the Prime Healthcare Foundation, is a full-service 331-bed non-profit acute care hospital."

During the past decade, Southern Regional Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 48 clinical trials were completed, i.e. on average, 4800% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 12 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Regional Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 30 trials, followed by "National Cancer Institute (NCI)" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Southern Regional Medical Center" are "Breast Cancer" (12 trials), "Lung Cancer" (9 trials), "Lymphoma" (8 trials), "Colorectal Cancer" (4 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Southern Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Southern Regional Medical Center" are "Drug" (61 trials), "Other" (46 trials), "Biological" (32 trials), "Radiation" (14 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (24 trials), "Quality-of-Life Assessment" (12 trials), "Bevacizumab" (11 trials), "Paclitaxel" (10 trials) and "bevacizumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Southern Regional Medical Center" are 61 trials for "All" genders, 20 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Southern Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Southern Regional Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Southern Regional Medical Center has several departments that took part in Clinical trials: "Center of Hope for Cancer and Blood Disorders" - 2 trials